Expert insights reveal how 3D cellular models are revolutionising preclinical testing and clinical translation.

Explore how Shift Bioscience optimises cell models for gene discovery, enhancing rejuvenation therapies and age-related ...

Explore how MitoRx’s Myo4 is showing promise in combating obesity by restoring insulin sensitivity and reducing fat.

New research from the University of Sydney has uncovered a key brain protein involved in the development of Parkinson’s disease, and identified a way to modify it, offering hope for future treatments.

By creating new algorithms and embedding the context of relationships among them, the LLM can act like a librarian who knows where to search among the library’s stacks, as well as how the books you ...

Scientists have developed a new technology that can predict how bowel cancer adapts to treatment – a breakthrough that could lead to more personalised therapies and improved patient outcomes in the ...

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Explore the role of non-human primates in drug development and the ethical challenges associated with their use in research.

Explore the groundbreaking achievements in quantum as Kipu Quantum and IonQ solve a complex protein folding problem on ...

Drug discovery often pushes the boundaries of what we understand. John Lepore, MD, CEO of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, is furthering that challenge by redefining where ...

Overcoming a key delivery challenge A long-standing challenge in using lipid nanoparticles (LNPs) is their tendency to accumulate in the liver, where they are filtered out by the reticuloendothelial ...